Cancer GeneticsWeb
www.cancer-genetics.org
Navigate
Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment.
  Melanoma

Mutated Genes and Abnormal Protein Expression (30)
Overview of the Molecular Biology of Melanoma
Familial Melanoma and Nevi
Melanoma: Clinical and Epidemiological Resources
  Mutated Genes and Abnormal Protein Expression
GeneLocationTopics
NRAS1p13.2 -NRAS and Melanoma
ARHC ( RhoC ) 1p21-p13 -RhoC and Metastases in Melanoma
CMM1p36  
S100A6 ( CABP , PRA , CACY ) 1q21 -S100A6 Expression in Melanoma
S100A2 ( CAN19 , S100L ) 1q21 -S100A2 Expression in Melanoma
KISS1 ( KiSS-1 ) 1q32 -KISS1 and Melanoma
MDA7 ( ST16 ) ? -MDA1 Expression in Melanoma
BIN1 ( AMPHL , SH3P9 ) 2q14 -BIN1 and Melanoma
CTNNB1 ( CTNNB ) 3p22-p21.3 -CTNNB1 and Melanoma
GRO1 ( SCYB1 , MGSA ) 4q12-q13  
IL45q31.1 -IL4 Gene Transfer for Melanoma (Experimental)
TFAP2A ( AP2 , AP2TF ) 6p24 -TFAP2A and Melanoma
AIM16q21 -AIM1 and Melanoma
CDKN2A ( P16 , INK4A , MTS1 ) 9p21 -CDKN2A Germline Mutations in Melanoma Prone Families
-Screening for CDKN2A Mutations in Melanoma Prone Families
-CDKN2A Polymorphisms and Mole Density ?
-CDKN2A Expression and UVB Irradiation
MCAM ( MUC18 , CD146 )  
MMP1 ( CLG ) 11q22-q23 -MMP1 and Malignant Melanoma
MMP3 ( STMY , STMY1 ) 11q23 -MMP3 and Malignant Melanoma
CD63 ( MLA1 , ME491 ) 12q12-q13  
CDK4 ( PSK-J3 ) 12q14 -CDK4 Germline Mutations in Melanoma Prone Families
EFNB2 ( EPLG5 , LERK5 , ephrin-B2 ) 13q33 -EFNB2 Expression in Melanoma
MMP2 ( CLG4A , CLG4 , GELA ) 16q13 -MMP2 and Malignant Melanoma
MC1R ( MSH-R ) 16q24.3 -MC1R Polymorphisms and Melanoma
TP53 ( p53 , P53 ) 17p13.1 -TP53 and Melanoma
TIMP217q25 -TIMP2 and Malignant Melanoma
MIA19q13.32-q13.33 -MIA and Melanoma
S100B21q22.2-q22.3 -S100B Expression in Melanoma
TIMP1 ( EPO , CLGI , TIMP ) Xp11.3-p11.23 -TIMP1 and Malignant Melanoma
MAGEA1 ( MAGE1 , MZ2-E ) Xq28 -MAGEA1 and Melanoma
MAGEA2 ( MAGE2 ) Xq28 -MAGEA2 and Melanoma
MAGEA3 ( MAGE3 ) Xq28 -MAGEA3 and Melanoma

 

  Overview of the Molecular Biology of Melanoma

  • Piepkorn M Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. J Am Acad Dermatol 2000 May;42(5 Pt 1):705-22; quiz 723-6    Related articles (PubMed)

  • Bittner M et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 2000; 406, 536 - 540

  • Castellano M, Parmiani G Genes involved in melanoma: an overview of INK4a and other loci. [Review] Melanoma Res 1999 Oct;9(5):421-32    Related articles (PubMed)

  • Radhi JM Malignant melanoma arising from nevi, p53, p16, and bcl-2: expression in benign versus malignant components. J Cutan Med Surg 1999; 3(6):293-7    Related articles (PubMed)

  • Kahari VM, Saarialho-Kere U Matrix metalloproteinases and their inhibitors in tumour growth and invasion. [Review] Ann Med 1999;31(1):34-45    Related articles (PubMed)

  • Kahari VM, Saarialho-Kere U Matrix metalloproteinases in skin. [Review] Exp Dermatol 1997;6(5):199-213    Related articles (PubMed)

  • Medline Search: melanoma AND genetics (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Melanoma Genetics
    Melanoma : Clinical and Epidemiological Information

     

  •   Familial Melanoma and Nevi

    Germline mutations in the CDKN2A gene have been identified in about 20% of melanoma-prone families. Melanoma families with CDKN2A germline mutations also have an excess risk of pancreatic cancer. Other genes implicated in familial melanoma include the CMM1 locus (1p36) had been implicated, but a number of studies indicate this is not involved, including an Australian study of 7 pedigrees. There have also been annecdotal reports of germline mutations in the CDK4 gene (12q14).

    The most common form of hereditary melanoma is familial atypical multiple mole-melanoma (FAMMM) syndrome. Dutch sudies indicate that germline mutations of CDKN2A are detected in 40-50% of cases. Familial dysplastic nevi is also associated with melanoma. Investigators at the Mayo Clinic reported a family in which cutaneous malignant melanoma or cerebral astrocytoma, or both, developed in eight members over three generations, possibly representing a new genetic disorder. Germline deletions of 9p21 occur in these families, and p19 has is a proposed candidate gene.

  • Greene MH The genetics of hereditary melanoma and nevi: 1998 Update. Cancer 1999; 86(S11):2464-2477    Related articles (PubMed)

  • Gruis NA, et al. Familial melanoma; CDKN2A and beyond. J Investig Dermatol Symp Proc 1999; 4(1):50-4    Related articles (PubMed)

  • Nancarrow DJ, et al. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. Genomics. 1992; 12(1):18-25    Related articles (PubMed)

  • Kaufman DK, et al. A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma. Neurology 1993; 43(9):1728-31    Related articles (PubMed)

  • Carey WP Jr, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994 Dec 15;74(12):3118-25    Related articles (PubMed)

  • Novakovic B, et al. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol. 1995; 33(4):631-6    Related articles (PubMed)

  • Medline Search: hereditary melanoma (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Melanoma Genetics
    Melanoma : Clinical and Epidemiological Information

     

  •  [Home]       © Copyright 1999-